- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Breast cancer
- Meeting Date: March 2023
- Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 2.3MB)
- Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 2.2MB)
Abemaciclib – March 2023
Abemaciclib: Tablet 50 mg, Tablet 100 mg, Tablet 150 mg; Verzenio®
Last updated
30 June 2023